louisakewell, Author at European Medical Journal - Page 39 of 153

EMJ

Clinical Case of ASV in a Patient with Heart Failure and Preserved Ejection Fraction

Michael Arzt presents a clinical case of ASV in HFpEF.

EMJ

Management of SDB with Adaptive Servo Ventilation

Symposium at the Sleep&Breathing meeting in April 2017 in Marseille (France).

RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA® for Acute Gastroenteritis

Tel-Aviv, Israel, Raleigh, USA, 14 June, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”)…

Acarix Receives First Commercial Order for CADScor®System for Early Detection of Coronary Artery Disease from Danish Hospital

Malmö, Sweden, 13 June, 2017 – Acarix AB (publ) (“Acarix” or the “Company”) today announced that Herning Hospital has placed the first commercial order…

New LEADER Analysis Shows Victoza® Reduces Cardiovascular Risk in People With Type 2 Diabetes Regardless of Severe Hypoglycaemia Events

New LEADER analysis shows Victoza® reduces cardiovascular risk in people with Type 2 Diabetes regardless of severe hypoglycaemia events.

PharmaMar Announces Encouraging Results in Clinical Trials of Lurbinectedin in Endometrial and Breast Cancers

PharmaMar announces encouraging results in clinical trials of Lurbinectedin in endometrial and breast cancers. Find out more

EMJ

Professor Edwards’ Invitation to Biogen’s Satellite Symposium at EULAR 2017

Video Invitation from Chris Edwards (Professor of Clinical Rheumatology, University of Southampton, UK) to Biogen’s Satellite Symposium at EULAR 2017…

Abiraterone Acetate Plus Prednisone Provided Significant Clinical Benefit in Patients with High-Risk Metastatic Hormone-Naïve Prostate Cancer (mHNPC), Improving Overall Survival and Radiographic Progression-Free Survival

Beerse, Belgium, 3 June, 2017 – Janssen-Cilag International NV today announced data from the pivotal Phase 3 LATITUDE clinical trial, which showed Zytiga…

Introducing EMJ Hepatology 5.1

United Kingdom, June 08, 2017: Welcome to the latest edition of our EMJ Hepatology eJournal! This issue is jam-packed with the latest hepatological…

Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting

Oxford, UK and Conshohocken, US, 5 June, 2017 – Immunocore Limited, the world’s leading TCR company developing biological drugs to treat cancer…